QUALITY-OF-LIFE IN ALZHEIMERS-DISEASE

被引：33

作者：

HOWARD, K ^{[1
]}

ROCKWOOD, K ^{[1
]}

机构：

[1] DALHOUSIE UNIV, DIV GERIATR MED, HALIFAX, NS B3H 3G2, CANADA

来源：

DEMENTIA | 1995年 / 6卷 / 02期

关键词：

QUALITY OF LIFE; ALZHEIMERS DISEASE; DEMENTIA; CLINICAL TRIALS; MEASUREMENT;

D O I：

10.1159/000106931

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We reviewed and independently ranked the measurement properties of quality of life (QL) instruments currently used in anti-dementia drug trials for Alzheimer's disease. Of 36 read reports, 5 measured and 4 mentioned QL. Eight instruments, labelled QL measures, included questionnaires measuring function, self-rating instruments measuring the caregivers' impression of the impact of sickness and deterioration of memory, and observational rating scales measuring function. The most thoroughly tested QL measure was the Progressive Deterioration Scale. The instruments with the most promising measurement properties were the Progressive Deterioration Scale and the Italian Quality of Life Scale. Most instruments now used to assess QL in antidementia drug trials have not been adequately validated in patients with Alzheimer's disease. Effort should be directed both to conceptual and practical development in the assessment of QL in dementia.

引用

页码：113 / 116

页数：4

共 28 条

[1]

BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637

[2]

BERGNER M, 1987, MEASURING HLTH GUIDE, P290

[3] OXIRACETAM IN DEMENTIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].

BOTTINI, G ;

VALLAR, G ;

CAPPA, S ;

MONZA, GC ;

SCARPINI, E ;

BARON, P ;

CHELDI, A ;

SCARLATO, G .

ACTA NEUROLOGICA SCANDINAVICA, 1992, 86 (03) :237-241

[4]

COLE M G, 1983, Journal of Clinical and Experimental Gerontology, V5, P219

[5] A DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY OF TACRINE FOR ALZHEIMERS-DISEASE [J].

DAVIS, KL ;

THAL, LJ ;

GAMZU, ER ;

DAVIS, CS ;

WOOLSON, RF ;

GRACON, SI ;

DRACHMAN, DA ;

SCHNEIDER, LS ;

WHITEHOUSE, PJ ;

HOOVER, TM ;

MORRIS, JC ;

KAWAS, CH ;

KNOPMAN, DS ;

EARL, NL ;

KUMAR, V ;

DOODY, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (18) :1253-1259

[6]

DEJONG R, 1989, CLIN THER, V11, P545

[7]

GOAD DL, 1991, J CLIN PSYCHIAT, V52, P342

[8]

GUINOT P, 1985, IRCS MED SCI-BIOCHEM, V13, P965

[9]

GUYATT GH, 1989, CAN MED ASSOC J, V140, P1441

[10] BEHAVIORAL-EVALUATION OF ALZHEIMER-DISEASE IN CLINICAL-TRIALS - DEVELOPMENT OF THE JAPANESE VERSION OF THE GBS SCALE [J].

HOMMA, A ;

NIINA, R ;

ISHII, T ;

HASEGAWA, K .

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1991, 5 :S40-S48

← 1 2 3 →